Cyp2a12 - cytochrome P450, family 2, subfamily a, polypeptide 12 Gene

Species: Mus musculus

Gene Type: protein coding
Gene ID: 13085

Summary

Predicted to enable enzyme binding activity; heme binding activity; and monooxygenase activity. Predicted to be involved in coumarin metabolic process; epoxygenase P450 pathway; and xenobiotic metabolic process. Predicted to be located in cytoplasmic microtubule. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver. Human ortholog(s) of this gene implicated in nicotine dependence and warfarin resistance. Orthologous to human CYP2A13 (Cytochrome P450 family 2 subfamily A member 13); CYP2A6 (Cytochrome P450 family 2 subfamily A member 6); and CYP2A7 (Cytochrome P450 family 2 subfamily A member 7). [provided by Alliance of Genome Resources, Apr 2022]

Cyp2a12 Products (2)

mRNA Protein Name
NM_133657.1 NP_598418.1 cytochrome P450 2A12 precursor
NM_133657.1 NP_598418.1 cytochrome P450 2A12 precursor
Protein Preferred Names Protein Names

cytochrome P450 2A12

  • CYPIIA12

  • cytochrome P450, 2a12

  • steroid hormones 7-alpha-hydroxylase

  • testosterone 7-alpha-hydroxylase

Related Agents

  • Approval
  • Pre-clinical Phase

Approval

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B1042 Oxolamine citrate Inhibitor 99.87% Unkown
HY-B1717 Oxolamine Inhibitor / Unkown

Pre-clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-122277 1'-Hydroxy bufuralol ≥97.0% Unkown
HY-122277S 1'-Hydroxy bufuralol-d9 99.9% Unkown
HY-B0822S1 Fipronil-13C6 98% Unkown
HY-B1717A Oxolamine hydrochloride Inhibitor / Unkown
HY-167632 meso-Zeaxanthin 93.09% Unkown